2008

1. Liver toxicity of antiretroviral combinations including atazanavir/ ritonavir in patients co-infected with HIV and hepatitis viruses: Impact of pre-existing liver fibrosis

   Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 4, pp. 925-932

2. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

   HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313